24 July 2025 in Turkish Archives of Otorhinolaryngology
Sinonasal Phosphaturic Mesenchymal Tumor: A Case Report - Turkish Archives of Otorhinolaryngology
26 September 2025 in OSMANGAZİ JOURNAL OF MEDICINE
Bullous pemphigoid is the most common vesiculobullous autoimmune disease, and clinically, peripheral eosinophilia is observed in half of the patients. This study aimed to analyze the relationship between tissue eosinophil count and peripheral eosinophilia, mucosal involvement, disease severity, and treatment response. Skin biopsies from seventy-seven patients diagnosed with bullous pemphigoid were re-evaluated. Patients were classified according to tissue eosinophil count as having low (1–20 eosinophils/HPF) or high (>20 eosinophils/HPF) eosinophil counts. Additional data, such as peripheral blood eosinophil count and treatment response, were also recorded. The mean age of the patients was 75.08 years (range: 36–95), and 51.9% were female. Tissue eosinophil counts ranged from 1 to 167, with a mean of 28.79. Peripheral eosinophilia was detected in 39% of the patients. A significant correlation was found between peripheral eosinophilia and tissue eosinophil count (p<0.001). The high peripheral eosinophilia group had significantly more extensive disease (p=0.034), and patients with peripheral eosinophilia had a higher rate of complete remission (p=0.027). No significant association was found between tissue eosinophil count and ESR, CRP, mucosal involvement, lesion severity, or treatment response. Tissue eosinophil count and peripheral eosinophilia are closely related. While peripheral eosinophilia was associated with disease severity and treatment response, tissue eosinophil count was not correlated with clinical features. Different results have been reported in the literature. High comorbidity and advanced age, combined with difficulties in disease control and lack of standardized treatment protocols, are believed to contribute to the variability observed across studies.
30 December 2022 in Düzce Tıp Fakültesi Dergisi
Aim: Bone tissue is the primary organ of hematopoiesis and osteogenesis in healthy individuals. Bone tissue is one of the most frequently metastasized organs. In addition, for all types of cancer, it is an indication that cancer has reached a level where it can no longer be cured and the patient's life expectancy is reduced. The aim of this study was to retrospectively evaluate the cases operated for bone metastasis. Material and Methods: A total of 67 patients who underwent a biopsy or operation due to bone tumors at Eskişehir Osmangazi University Medical Faculty Hospital between January 2020 and January 2022 were included in this study. Results: Of the metastatic cases, 49 (73.1%) were male and 18 (26.9%) were female. The mean age of the patients was 61.7±19.8 (range, 9-88) years. The most frequently metastasized tumors were lung carcinoma and tumor of unknown primary in males, while lung and breast in females. Tumors most frequently metastasize to the spine region. There were 6 (9.0%) cases, 1 (1.5%) of which was mesenchymal, in which the primary origin couldn’t be detected in metastatic tumors. Conclusion: Bone pain is always a symptom that is suspicious for metastasis in a patient followed up with a diagnosis of cancer and requires further investigation. Treatment is more palliative after bone metastasis. There is a need for targeted studies to prevent metastasis. It should be kept in mind that the primary focus may not be detected in all clinical and imaging methods in a group of patients.
28 February 2026 in Eskisehir Medical Journal, Eskisehir City Hospital
Introduction: Vulvar squamous cell carcinomas (SCCs), although rare, are tumors with a high malignant potential and limited therapeutic options. This study aimed to investigate the expression of Lin28A—a molecule recently associated with various tumors and considered a promising target for therapy—in vulvar SCC, as well as its potential prognostic significance. Methods: Biopsies from 40 cases diagnosed with vulvar SCC were retrospectively re-evaluated, and Lin28A immunohistochemical staining was applied to suitable tumor blocks. Clinical and pathological features were recorded. Results: The mean age of the patients was 69.05 years, with a mean follow-up duration of 53.5 months. Recurrence was observed in 56.8% of cases, and mortality was recorded in 69.2%. Lin28A positivity was detected in 42.1% of tumors. Significant associations were found between greater depth of invasion, advanced clinical stage, recurrence, and mortality. Although a higher mortality rate was noted in Lin28A-positive cases, the difference was not statistically significant. Conclusions: This study represents the first report investigating Lin28 expression in vulvar SCC, a molecule previously studied in various malignancies such as gastric, lung, liver cancers, and head and neck SCC, where it has been shown to have an adverse prognostic impact. Although the prognostic effect could not be definitively demonstrated due to the limited sample size, a relatively high expression rate was observed. Lin28 may represent a potential therapeutic target, particularly in cases presenting with recurrence and metastasis.